Overview
This article describes the production and purification of recombinant adeno-associated virus (rAAV) vectors for in vivo studies. The method allows for effective transgene delivery and accurate titering of viral stocks.
Key Study Components
Area of Science
- Neuroscience
- Gene Therapy
- Virology
Background
- Recombinant adeno-associated viruses are valuable tools for gene delivery.
- Traditional purification methods can be cumbersome and require toxic materials.
- Improved techniques can enhance yield and purity of viral vectors.
- HEC 293 cells are commonly used for rAAV production.
Purpose of Study
- To develop a protocol for producing rAAVs efficiently.
- To provide a method for accurate titering of viral stocks.
- To demonstrate the effectiveness of the produced rAAVs in transgene expression.
Methods Used
- Transfection of HEC 293 cells with plasmids encoding viral genes.
- Purification of rAAVs using heparin column chromatography.
- Titering of viral stocks through immunofluorescence microscopy.
- Use of sodium deoxycholate and benzonase for cell lysis and nucleic acid removal.
Main Results
- High yields of pure rAAVs were achieved without ultracentrifugation.
- Consistent titers of approximately 6 x 106 infectious particles per microliter were obtained.
- Immunofluorescence microscopy confirmed strong transgene expression.
- The method is efficient and avoids the use of toxic materials.
Conclusions
- The described protocol provides a reliable method for rAAV production.
- It offers advantages over traditional purification techniques.
- The rAAVs produced are suitable for both in vitro and in vivo applications.
What are recombinant adeno-associated viruses?
Recombinant adeno-associated viruses (rAAVs) are viral vectors used for gene delivery in various applications, including gene therapy.
How are rAAVs produced?
rAAVs are produced by transfecting HEC 293 cells with plasmids that encode the viral and transgene components, followed by purification.
What is the advantage of the purification method described?
The method avoids the use of ultracentrifugation and toxic materials, yielding higher purity and quantity of viral vectors.
How is the titer of rAAVs determined?
The titer is determined using immunofluorescence microscopy to count the number of infected cells at various dilutions.
What applications can rAAVs be used for?
rAAVs can be used for in vitro and in vivo gene delivery, including studies in gene therapy and functional genomics.
What cell line is used for rAAV production?
HEC 293 cells are commonly used for the production of rAAVs due to their high transfection efficiency.
繁體中文
